0f851fd93d5cfcaec258f1d6354c3416 *CITATION
c5251da11fec0accd756e5f925112887 *DESCRIPTION
2713e4d417a05083b218ff7ebecb38ed *INDEX
89775c4f6451ca9ade94e21c4428ef4e *Meta/Rd.rds
dbe02abdc8edc2f5c5b42c81885e8e29 *Meta/data.rds
50a9fa3e1aa2c47fa7bdbd6e6bb8974e *Meta/features.rds
07d989fa4a157a76d26158cd6ed97c52 *Meta/hsearch.rds
c4239426ab62cf5582d57ad4dd8280ce *Meta/links.rds
9a577625d56ea38a5da9b1407f5c9250 *Meta/nsInfo.rds
59981ddbeb8b02c4fe81e589523cdf4e *Meta/package.rds
b66eb803bc36e695335b91d0df2b88ef *Meta/vignette.rds
e1e62974ae02ddb7af02236e3e5d3949 *NAMESPACE
23e89529b16ec1de5d645b33a8f3be59 *NEWS.Rd
d6c68f1fe41ced6e98a766a3757313da *R/ChIPQC
84283b11eea34a9b4422c98745487ee0 *R/ChIPQC.rdb
9cba46a30916e017bdbd450464b0da66 *R/ChIPQC.rdx
611049c57721a5264020c67b2691b7fe *data/blacklist_hg19.RData
889b92ab22ccb5ce5e1730ba4e818e05 *data/datalist
f51456423d075f616c0511cd43510d91 *data/example_QCexperiment.RData
10160739db863b5a8fc53f937f770e5d *data/tamoxifen_QC.RData
66498ccd50994dcf71071e963c814e8a *doc/ChIPQC.R
5f7db2dfa44972eee84275b3ddddc50b *doc/ChIPQC.Rnw
ceb89363903d3f0be45906ad4a11d5da *doc/ChIPQC.pdf
94246221f5b6a1f68c12929c53709130 *doc/ChIPQCSampleReport.pdf
9232f679268f60f56f5759a9d3a6a0d2 *doc/index.html
7946fb2b4ad0e8db82ffcfd5c49dfbb5 *extdata/blacklist_hg19.bed
5df110abf9e3ec2405af4c7750f624bf *extdata/example_QCexperiment.csv
a8e6c3c4500562f10e19acc7daf9dee2 *extdata/tamoxifenQC.csv
bd814e9000683899c1666259593153fd *help/AnIndex
e6ef4a5ea448786bcebd85bcc97e327b *help/ChIPQC.rdb
d13dbc25b76f6440a9e950661ffc0b40 *help/ChIPQC.rdx
ce7a6750c6faf6c704a9e382643f7103 *help/aliases.rds
43307a6b0458b27b3c2f8762e31f7382 *help/paths.rds
3652a65bfc4751a996a198978208446f *html/00Index.html
ee41876c0116916bb04bcf4fe3e43d78 *html/R.css
9ba3ce9ceff392599f17b421b72dddb7 *legacy/report.r
